In addition, targeting BCL2 apoptosis regulator (BCL2) with exo-microRNA-34a significantly enhanced the expression of proapoptotic proteins such as BCL2 associated X, apoptosis regulator (Bax) and P53, which in turn inhibited tumor growth by promoting apoptosis[93]. The gene discussed is BCL2; the disease is neoplasm.